Publication number: 20120252866
Abstract: The invention relates to a compound having general formula I, wherein: X represents CH2, C?O, C?S or CHOH, R1 represents an amino acid optionally substituted by one or more halogen atoms, or by one or more CF3 groups and n=0.1 or 2, or R1 represents a peptide containing two amino acids, each amino acid being optionally substituted by one or more halogen atoms, or by one or more CF3 groups and n=0 or 1, or XR1 represent PO3H or SO3H and n=0.1 or 2; R2 represents H, XR1, an alkyl group at C1-C6, an aralkyl group at C1-C6 or an aryl group, whereby the alkyl, aralkyl and aryl groups can be substituted by an amine NH2, a carboxylic group COOH, one or more halogen atoms.
Type:
Application
Filed:
April 2, 2012
Publication date:
October 4, 2012
Applicants:
Centre National De La Recherche Scientifique (CNRS), PHARMAMENS
Inventors:
Pierre Potier, Guy Jean Marie Potier, Marie Claude Denise Michele Zelveyan, Catherine Marie Germaine Magnan, Odette Drion, Nobumichi André Sasaki, Maria Concepcion Achab Garcia Alvarez, Qian Wang-Zhu, Lioudmila Ermolenko, Joanna Bakala, Gisèle Franck, Naïma Bakrim Nhiri